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Abstract
The increasing use of quantitative real-time polymerase chain reaction (qPCR) as a method for
quantifying gene expression has led to an increased demand for standardization of data
analysis methods to ensure accurate reporting and robust, reproducible results. The
exponential nature of qPCR amplification results in the potential magnification of what are
usually very small sources of error. Relative gene expression calculations circumvent this issue
by normalizing target gene expression data to within-sample expression of a previously
validated, stably expressed reference gene or genes. Multiple studies discussed herein have
found that qPCR data are more reliable and reproducible when multiple reference genes are
used, and that they are validated prior to use in experiments with new conditions. In this thesis,
existing reference genes are evaluated to ensure they meet these criteria in experimental
paradigms used frequently in our laboratory. Existing work on ethanol’s anxiolytic-like effects in
our laboratory utilized microarrays to identify Ninein as a cis-regulated, quantitative trait gene for
these effects in nucleus accumbens (NAc) of BXD recombinant inbred mice and their
progenitors, C57BL6/J (B6) and DBA/2J (D2) mice. Contrasting behavioral responses to
ethanol in these mouse strains make them a frequent subject of study for determining genetic
components underlying those behaviors. In the first data chapter, the case is made for
eliminating one reference gene typically used for qPCR data normalization in qPCR
experiments assessing strain differences in NAc gene expression in the laboratory, Ppp2r2a.
The reference genes subsequently validated for use in qPCR analysis in ethanol-naïve NAc and
amygdala of saline and ethanol-treated B6 and D2 mice are then used in an in-depth
characterization of Ninein expression in B6 and D2 NAc and amygdala. Furthermore, evidence
is provided for the first in vivo observation of murine Ninein transcript variant 6 in adult neural
tissue. The data presented make the case for a more thorough re-evaluation of reference
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genes for future qPCR experiments in the laboratory, as well as a potential mechanism for
Ninein’s involvement in variation of anxiolytic-like responses to ethanol in B6 and D2 mice.
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Chapter 1 Introduction and Background
Neurobiology of Alcohol Use Disorders
It has been recently estimated that 1 in every 19 people aged 12 or older in the United
States suffer from an alcohol use disorder (AUD) (SAMHSA, 2019). In the Diagnostic and
Statistical Manual of Mental Disorders (APA, 2013), AUDs are characterized by persistent
alcohol use despite negative personal, social, psychological and/or physiological consequences,
as well as craving, tolerance, and withdrawal. Neurobiologically, increased activity in the
mesolimbic dopamine system - including the nucleus accumbens (NAc), ventral tegmental area
(VTA), and prefrontal cortex (PFC) - mediates the acute rewarding effects of ethanol and other
drugs of abuse. Neuroplasticity in these regions over a period of consistent alcohol use is
thought to be the underlying factor in the transition from acute alcohol abuse to the chronic,
compulsive drinking behavior seen in AUD (see Volkow & Koob, 2010 for review). Thus,
existing work in the laboratory has focused on the mesocorticolimbic reward circuit due to the
extensive evidence for its role in drug reward and dependence.
The extended amygdala also plays a key role in behavioral responses to both acute and
chronic ethanol exposure. The amygdala has extensive interconnectivity with the mesolimbic
system, including afferent projections from the PFC and hypothalamus, as well as efferent
projections to the PFC, NAc, hypothalamus, and BNST. Changes in activity or plasticity in the
amygdala have been associated with the rewarding effects of drugs and the preoccupation or
craving associated with the late stages of addiction (Volkow & Koob, 2010), and acute doses of
ethanol have been shown to alter c-Fos expression in the central amygdala and bed nucleus of
the stria terminalis (BNST) (Davis et al., 2009; Sharko et al., 2016). In addition, both amygdala
and BNST have been implicated in phasic and sustained fear in both rodents and humans
(Davis et al., 2009). Together, these data suggest that activity in the amygdala could play a
crucial role in the anxiolytic-like effect of ethanol.
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Genetics of Alcohol-Related behavior
Twin studies show that approximately 48%-58% of the liability for AUD risk is associated
with genetic factors (Prescott & Kendler, 1999; Tawa et al., 2016). Given the complex nature of
AUD-related symptoms and behaviors, it is not surprising that multiple genetic loci have been
associated with this risk (see Tawa et al., 2016 for review). Rodent models have become one of
the prevailing methods for studying the genetic components underlying complex ethanol-related
behavioral phenotypes due to divergent behavioral responses to acute and chronic ethanol in
existing inbred strains with known genotypes. C57BL/6J (B6) and DBA2/J (D2) mice are two
such examples of these contrasting behaviors. In multiple chronic drinking paradigms, B6 mice
drink more and have a greater preference for ethanol than D2 mice (Crabbe et al., 1999;
McClearn & Rodgers, 1959; Moore et al., 2010). B6 mice are also less sensitive to the
locomotor activating (Phillips et al., 1994) and sedative-hypnotic (Linsenbardt et al., 2009)
effects of ethanol, whereas D2 mice are less sensitive to ethanol's anxiolytic-like effects
(Putman et al., 2016). Because of their extensive behavioral characterization, B6 and D2 mice
have been used as progenitor strains for the BXD recombinant inbred (BXD RI) line of mice,
comprised of more than 100 inbred strains with known B6 or D2 alleles at almost 7500
polymorphisms across all chromosomes (Taylor, 1978; Williams et al., 2001). Correlating
variation in genotype with variation in behavior among these strains has allowed for quantitative
trait locus (QTL) mapping of several ethanol-related phenotypes including withdrawal (Buck &
Finn, 2001; Crabbe et al., 1999), hypnotic sensitivity measured with loss of righting reflex
(Radcliffe et al., 2000), locomotor activation and motor incoordination (Demarest et al., 1999;
DuBose et al., 2013; Phillips et al., 2010), metabolism (Grisel et al., 2002), anxiolysis measured
in the elevated zero maze (Cook et al., 2015), and anxiolysis measured in the light-dark box
(Putman et al., 2016).
Associations between anxiety and alcohol use have long been reported in scientific
literature, and patients with AUD often cite the anxiolytic properties of ethanol as the reason for
4

persistent use and abuse (Newlin & Thomson, 1990). As such, it is not surprising that preexisting anxiety disorders are associated with an increased risk for the onset of comorbid
alcohol dependence (Crum et al., 2013; Swendsen et al., 2010). With mounting evidence for
heritable components of both AUD and anxiety disorders (Hodgson et al., 2016; Prescott &
Kendler, 1999), our laboratory sought to identify behavioral QTL (bQTL) and expression QTL
(eQTL) underlying the anxiolytic effect of ethanol.
Ethanol-induced anxiolysis QTL 1 (Etanq1) was identified in nucleus accumbens using the
BXD recombinant inbred panel of mice in the light-dark transition model of anxiety (Putman et
al., 2016). Light-dark transition assays rely on the innate tendency of rodents to avoid bright
lights or open fields (Buccafusco, 2009). In brief, a mouse is placed in a chamber with an open,
brightly lit compartment and an enclosed dark compartment. Increases in time spent or
distance traveled in the light compartment after a given experimental treatment are interpreted
as anxiolytic-like behaviors. A mixed-model behavioral QTL analysis, incorporating the effects
of genotype and treatment on percent distance traveled (%DTL) and percent time spent (%TSL)
in the light after treatment with 1.8 g/kg ethanol or saline, was used to identify Etanq1 on
chromosome 12. Because of a potential interaction with a second QTL on Chr 1, the QTL was
further refined using six additional BXD strains with either B6 or D2 alleles at its peak marker,
and balanced for B6 and D2 alleles at a chromosome 1 locus with an epistatic interaction with
Etanq1. Differences in %DTL after ethanol treatment were still significant despite variation at
the Chr1 locus. Fine-mapping of the initial 18 Mb support interval, using 3 additional BXD
strains with recombination events within Etanq1, narrowed the interval to about 3 Mb that
includes 41 protein coding genes and genes with non-coding RNAs. Of 10 missense SNPs
identified in this interval, the only SNP predicted to alter protein function in a deleterious manner
(rs29159683) was within Ninein (Nin). To determine whether BXD genotype affected mRNA
expression, microarrays were performed with tissue from prefrontal cortex (PFC), nucleus
accumbens (NAc), and ventral midbrain (VMB). Genes within Etanq1 whose expression varied
5

with genotype, i.e. had cis-eQTLs, included Sos2 in VMB, and Nin, Atp5s, Trim9, and Sos2 in
NAc. When correlating candidate gene expression with ethanol-induced anxiolysis, only Nin,
Sos2, and Trim9 expression in the NAc were significantly correlated with %DTL after ethanol
injection. Relative expression of Nin, Trim9, and Sos2 in NAc of B6 and D2 mice were
measured using qPCR, and only Nin was differentially expressed between strains. Allele
specific qPCR in B6D2F1 mice revealed higher expression of mRNA containing the D2 allele,
confirming its cis-regulation, and western blots show higher expression of two provisional NIN
protein isoforms in D2 NAc as compared to B6 (Putman et al., 2016).

Validating Quantitative Trait Genes from microarray data using quantitative real-time
polymerase chain reaction (qPCR)
qPCR is frequently used to validate microarray results because of its high sensitivity,
specificity, and wider dynamic range. In the context of quantitative trait gene (QTG) validation,
qPCR serves as a less expensive and more rapid parallel method for evaluating expression
differences of a smaller number of candidate genes between progenitor strains with more
biological replicates for higher statistical power.
There are two widely used fluorescence methods available for these purposes, namely
SYBR Green and TaqMan technologies. SYBR green dyes are non-specific and intercalate all
double stranded nucleic acids. Thus, qPCR experiments utilizing this method rely on the
assumption that the only double stranded products in the reaction are those produced by primer
binding to a single specific target. In contrast, probes in TaqMan reactions contain a reporter
fluorophore and corresponding quencher in close proximity. During the extension phase of the
PCR reaction Taq polymerase cleaves the probe, separating the fluorophore from the quencher
and allowing it to fluoresce. For this reason, TaqMan reactions are capable of amplifying
targets with very low copy numbers, while the sensitivity of SYBR Green reactions is reliant
upon the specificity and binding efficiency of target primers. The utilization of different
6

fluorophores on TaqMan probes for different targets can also allow for quantification of multiple
targets in a single reaction, which can be useful when starting RNA quantities are very low.
Reactions with SYBR Green dyes, on the other hand, are limited to amplification of a single
target per reaction. The complex nature of TaqMan probes, however, are often cost prohibitive
and frequently limited to pre-designed probes. Primers for SYBR Green PCR are typically much
cheaper, allowing for quick, user-based design of primers for a variety of targets. As a result,
SYBR Green is often the method of choice when using qPCR to quantify expression of multiple
target QTGs.
The primary focus of behavioral QTL and QTG validation is usually quantifying relative
differences in expression of target genes between experimental groups. In other words: Is the
direction of variation in expression of the target gene directly or inversely correlated with the
direction of variation in magnitudes of the behavior of interest? As opposed to: What specific
copy number of a target mRNA corresponds to a specific magnitude of behavior? In cases
where absolute quantification is either unnecessary or not possible due to the lack of standards
with known copy number, relative quantity (Ct method) or normalized expression (2-Ct
method) is used. Relative quantity is calculated as the fold change relative to either an
"untreated" control sample or to a standard curve with serial dilutions of known cDNA mass.
Relative quantity calculations rely on the assumption that the starting amount of cDNA template
in all reactions is identical, which is often not the case due to small variations in quantity
introduced during total RNA quantification prior to reverse transcription, and pipetting error
during the setup of PCR reactions. To compensate for this error, the 2 -Ct method employs a
previously validated internal control gene(s), or "reference gene", to normalize sample Ct values
of target genes. The 2-Ct method uses target gene Ct values normalized to reference gene Ct
values to compare target gene expression in a treatment sample to an untreated control, where
Ct is the cycle threshold of fluorescence in a given sample, Ct is the difference between target
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gene Ct and reference gene Ct for the same sample, and Ct is the difference between the
Cts of the treated sample and a control (Livak & Schmittgen, 2001).
The wide variety of RNA isolation methods, qPCR fluorophores, thermocycler protocols, and
data analysis methods paired with the variation in reporting of validation methods and data often
results in low reproducibility of qPCR experiments within and between labs. As a result, the
Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE
Guidelines) were developed (Bustin et al., 2009). The MIQE guidelines are recommendations
for the submission of data collected at multiple phases of qPCR experiments prior to and after
the actual target amplification, including experiment design, sample preparation, nucleic acid
extraction methods, reverse transcription methods, target gene information, primer and
reference gene validation, thermocycler protocol, reagents used, and data analysis methods.
One of the MIQE guidelines most frequently missing from publications is the validation of
reference genes used for normalization (Bustin et al., 2013). The selection of appropriate
reference genes is vital given their function in data normalization. In order for a reference gene
to be valid, it must be stably expressed across all experimental groups and/or tissues being
investigated, and its amplification efficiency should be comparable to that of the target gene
(Livak & Schmittgen, 2001). Frequently, qPCR data are presented normalized to a single
reference gene presumed to be stably expressed in all tissues, such as Actb or Gapdh
(Czechowski et al., 2005). Use of a single, non-validated reference gene can lead to the
appearance of expression differences 3- to 6-fold higher than are actually present (Hellemans &
Vandesompele, 2014). Vandesompele and colleagues (2002) developed a method and
software for calculating expression stability of candidate reference genes called GeNorm.
GeNorm utilizes the pairwise variability of relative quantities of candidate reference genes
between samples to designate the most stably expressed genes, as well as the minimum
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number of reference genes necessary to accurately quantify target gene expression across all
experimental groups.
The primary goal of the work in this thesis is to find suitable reference genes for comparison
of gene expression between in the NAc and amygdala of B6 and D2 mice treated with acute
doses of ethanol. Re-assessment and further characterization of Ninein expression, the
suspected QTG underlying the QTL for ethanol-induced anxiolytic-like response to ethanol in
mice (Etanq1), will be presented as a functional validation of the use of proper reference genes
for qPCR experiments.
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Chapter 2 Reassessment and Design of Reference Genes for Comparison of Gene
Expression in B6 and D2 Mice Exposed to Acute Ethanol
Introduction
Quantitative real-time polymerase chain reaction (qPCR) is a widely used method for
measuring gene expression in a broad variety of cell types and tissues. Although absolute
quantification of target mRNA copy number is possible, it requires the availability of calibrated
external standards with known copy number or concentration. These standards can be obtained
from plasmids containing the gene of interest (GOI), synthetic nucleotides with the sequence of
the amplicon desired, or cell lines with known expression levels of the GOI (see Arya et al.,
2005 for review). This can be problematic when these resources are either unavailable or
costly to produce, and is often unnecessary in experiments where the research question is
based on relative expression of a GOI between treatment or time groups. In these instances,
measurement of relative quantities (Ct) or normalized expression(2-Ct) is used in lieu of
absolute quantification (Livak & Schmittgen, 2001).
The use of the Ct method for reporting gene expression is limited by the assumption
that the amount starting quantity of template in each reaction well is equal. Instrumental error in
nucleic acid quantification and pipetting error often introduce small variations in starting quantity
that render this assumption invalid. As a result, the 2 -Ct method has been widely adopted as
an alternative. In this method, GOI Cts in all experimental samples are normalized to reference
gene Cts in the same samples prior to group comparisons in order to eliminate the error
produced by small variation in starting quantities. Reference genes in these experiments
require prior validation of stable expression across all experimental groups, and their primers
must have amplification efficiencies similar to GOI primers (Livak & Schmittgen, 2001).
Because the expression level of a particular gene can vary across strains, sexes,
tissues, cell types, and treatment groups, it is important to verify that the reference gene and
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primers used meet both of these criteria. When the expression level of a reference gene is very
low, primer efficiency can be greatly impacted. A reference gene proven to be stably expressed
across, for instance, PFC in B6 and D2 mice with and without ethanol exposure may not be
stably expressed in NAc under the same conditions. Similarly, a reference gene that is stably
expressed between strains in basal conditions may not be stably expressed in the presence of
drug treatment, or throughout development. Unfortunately, much of the existing qPCR literature
utilizing reference genes for data normalization do not report validating these conditions prior to
performing their experiments (Bustin et al., 2013). It is also common practice to use a single
reference gene, when in reality qPCR data normalization is typically more accurate with the use
of at least three (Derveaux et al., 2010; Vandesompele et al., 2002).
In an attempt to keep with these standards, this chapter describes the use of publicly
available bioinformatic tools and published genome-wide datasets to identify candidates for use
as reference genes in qPCR experiments comparing gene expression in B6 and D2 amygdala
and NAc with and without an acute dose of ethanol. This is followed by experimental validation
of these reference genes and their primers using relative quantification and GeNorm software.

Methods and Materials
In-silico evaluation
Databases, Bioinformatic Tools, and Software
Robust Multi-array Average (RMA) values and S-scores from nucleus accumbens (NAc)
were obtained from GeneNetwork databases GN154, GN155, GN156, containing Affymetrix
GeneChip Mouse Genome 430 2.0 arrays from B6, D2, and BXD male mice dissected four
hours after an IP injection with saline or 1.8g/kg ethanol (Kerns et al., 2005). RMA values from
basolateral amygdala were obtained from GeneNetwork database GN323, containing pooled
Affymetrix GeneChipTM Mouse Gene 1.0 ST arrays from untreated male and female mice
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(Mozhui et al., 2010). Microarray data from amygdala in ethanol treated mice were not
available.
NCBI Primer BLAST tool was used to generate potential primer sequences, using the
RefSeq accession number for one or all transcripts for target genes. NCBI Nucleotide BLAST,
UCSC in-silico PCR and UCSC BLAT tools were used to scan for overlap of mRNA and primer
sequences in non-specific locations. IDT UNAfold was used to evaluate the secondary
structures of primers. Websites for all databases and in silico tools used are listed in Table 2.1

Candidate gene ID
The genes evaluated for potential use as reference genes were pooled from an overlap
between those used in the mouse GeNorm kit (n = 10) available from Primerdesign Ltd.
(Camberley, UK), genes currently used as reference genes in the laboratory (n = 8), and a BXD
gene set from microarrays in NAc filtered for ethanol S-scores between -2 and 2 and with mas4
scores above 100 (n = 4985).
Candidate genes from the resulting list were eliminated if:


B6 and D2 mice had different RMA values for that gene in NAc and/or amygdala,
suggesting differential expression levels between the strains.



Either strain had a significant S-score (|S-score|>2) when comparing saline to
ethanol-treated mice, suggesting ethanol regulates expression of the gene,



B6 and D2 mice had significantly different (|S-score|>2) S-scores for the target gene



More than 30% of the target gene sequence shared greater than 80% sequence
identity with other genes, other gene transcripts, or non-coding chromosomal regions



The target gene had pseudogenes
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Bioinformatics Tool
GeneWeaver

URL
https://geneweaver.org/

GeneNetwork
NCBI PrimerBLAST

http://www.genenetwork.org/webqtl/main.py
https://www.ncbi.nlm.nih.gov/tools/primer-blast/

UNAfold
NCBI Nucleotide BLAST

https://www.idtdna.com/UNAFold?
https://blast.ncbi.nlm.nih.gov/Blast.cgi

UCSC BLAT
UCSC in-silico PCR

http://genome.ucsc.edu/cgi-bin/hgBlat
http://genome.ucsc.edu/cgi-bin/hgPcr?db=hg38

NCBI RefSeq
GeNorm

https://www.ncbi.nlm.nih.gov/refseq/
https://genorm.cmgg.be/

RefSeq

https://www.ncbi.nlm.nih.gov/refseq/

Table 2.1 Websites used for bioinformatic analyses of candidate reference genes

Parameter

Target Value

Product size

Minimum: 70 bp
Maximum: 400 bp

Primer Melt Temperature

Minimum: 57
Optimum: 60
Maximum: 65
Maximum Difference: 2

Exon junction overlap
Organism ID

At least one primer must span an exon exon junction
Mus musculus (taxid: 10900)

Primer Length

Minimum: 19 bp
Optimum: 20 bp

Primer GC Content

Maximum: 25 bp
Minimum: 20%

3' GC clamp

Maximum: 65%
1

Max Self Complementarity

Any: 5.00
3': 3.00

Max Pair Complementarity

Any: 5.00
3': 3.00

SNP Handling

Primer binding site may not contain a known SNP

Table 2.2 Primer design criteria
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Primer Design
Existing primer pairs in the laboratory were redesigned if NCBI nucleotide BLAST,
UCSC in-silico PCR, or UCSC BLAT searches revealed one or both primers:


Were located in the 3'-untranslated region of a transcript



Did not overlap an exon junction



Had non-specific binding sites



Did not bind all known mRNA transcript variants of the given gene

Otherwise, new primer pairs were designed with NCBI's PrimerBLAST using the default search
parameters except for the criteria listed in Table 2.2. Primer annealing temperature, PCR
product length, primer length, GC content, and self-complementarity were chosen in order to
maximize efficiency in PCR reactions using SYBR Green Master Mix. Target mRNA specificity
was optimized by eliminating primers that overlapped strain-polymorphisms (dbSNP) and
requiring at least one primer to overlap an exon junction. Potential primer secondary structures
and their melting points were evaluated using IDT-UNAfold, and primer sequences were
discarded if the melt temperature of those secondary structures was not significantly less than
the predicted annealing temperature of the primer.

In vivo validation
Animals
Eight-week old male C57BL6/J and DBA2/J mice were obtained from Jackson
Laboratories (Bar Harbor, ME). Mice were housed four per cage on ventilated racks with Teklad
Sani-Chip bedding (currently Envigo, Cumberland, VA) and cotton nesting material. Animals
were subject to a 12-hour light-dark cycle and had ad-libitum access to Teklad LM-485 7012
standard rodent chow and tap water. Two weeks after their arrival, mice were administered
0.9% saline, 1.8 g/kg or 4 g/kg ethanol via intraperitoneal injection. Four hours following the
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injection, mice were sacrificed via cervical dislocation and decapitation in order to obtain brain
tissue for dissection. All procedures were approved by the Virginia Commonwealth University
Institutional Animal Care and Use Committee in accordance with National Institute of Health
guidelines.

Tissue Collection
Immediately after sacrifice, whole brains were removed and dissected as described by
Kerns et al. (2005). In brief, whole brain tissue was chilled for 1 minute in 1X phosphate buffer
on ice, then dissected to isolate amygdala, nucleus accumbens, prefrontal cortex, caudate
putamen, septum, hypothalamus, cerebellum, entorhinal cortex, and ventral midbrain. Tissue
sections were placed in individual tubes, flash frozen in liquid nitrogen, and stored in a -80C
freezer until RNA extraction.

Nucleic acid extraction and evaluation
Total RNA was isolated from amygdala and nucleus accumbens tissue as described
previously (Kerns et al., 2005) using homogenization in STAT-60 (Tel-test, Inc., Friendswood,
TX, USA) followed by RNA purification with a Qiagen RNeasy Mini Kit (Qiagen, Redwood City,
CA, USA). RNA concentration in each sample was quantified based on UV-Vis absorbance at
260nm using a ThermoFisher Nanodrop 2000 Spectrometer. Sample quality was assessed
using RNA Quality Indicator values acquired from analysis with a Bio-Rad Experion TM
Automated Electrophoresis System with Experion RNA StdSens analysis kits using the included
protocol. Per the Bio-Rad ExperionTM software protocol, samples with RNA quality indicator
(RQI) values lower than 7.0 were not included in qPCR experiments.
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Quantitative Real Time PCR (qPCR)
cDNA was synthesized from 1g total RNA using an iScript cDNA Synthesis kit (BioRad, Hercules, CA, USA), and qPCR was performed using iQ SYBR Green Supermix Kit and
CFX Connect Real Time System (Bio-Rad, Hercules, CA, USA). All qPCR amplifications were
carried out in sealed Bio-Rad hard-shell, semi-skirted, 96-well PCR plates with clear shells and
white wells. All reaction mixtures were 20 L; detailed parameters for each PCR experiment
protocol can be found in the results section and Appendix 2. In brief, for each primer pair,
temperature gradients were carried out with one technical replicate of one sample per strain
across a temperature range of 54C to 64C. Optimum annealing temperature was determined
based on gel electrophoresis experiments described below. Standard curves were obtained
using 3 technical replicates of one sample per region per strain in 1:5 serial dilutions with
nuclease free water resulting in cDNA quantities of 0.04ng, 0.2ng, 1ng, and 5ng. The annealing
temperature in the thermocycler protocol for standard curves was set to the optimum
temperature for each primer pair as determined in temperature gradient qPCR experiments. In
order to obtain preliminary data, temperature gradients and standard curves were carried out
using one biological replicate per region per strain. In future primer validation studies, it is vital
that at least three biological replicates per region per strain are used for robust results and
proper quantification of limit of detection (LOD) and limit of quantification (LOQ).

Gel Electrophoresis
Optimum annealing temperature for each primer pair was determined using agarose gel
electrophoresis. Following qPCR, five microliters of reaction mixture from each sample at each
temperature were run with 4% agarose and 1X GelRed (Biotium, Fremont, CA) in 1X TBE at
90 volts. Bands were visualized using a Kodak Image Station and Kodak 1D Image Analysis
Software (Eastman Kodak, Rochester, NY). Optimum annealing temperature for a primer pair
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was selected if the run temperature of a given reaction mixture produced a single band at the
predicted molecular weight of the product, appeared to have the highest quantity of product
relative to other run temperatures, and had no visible bands indicating the presence of primer
dimers at low molecular weights. Primer pairs that did not meet all of these criteria were
discarded.

Data Analysis
For standard curves, Cq values were calculated using the Bio-Rad CFX Manager 3.1
Software Single Threshold determination mode. Cq data and standard curves were analyzed
and plotted using Microsoft Excel 2016 for Mac. Efficiency was calculated using the following
equation:
% Efficiency (E)= -1+10

∗ 100

The final candidate genes and total number of reference genes to be used were selected using
the GeNorm macro V3.5 for Microsoft Excel previously downloaded from the GeNorm website.
Although this version is no longer available from its originators, the updated version is included
as part of Biogazelle's qbase+ software available at http://www.qbaseplus.com/.
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Results
In silico Analysis
In silico analyses reveal five candidate reference genes.
Overlap analyses of the three gene sets revealed twelve genes in common between at
least two of the sets (Figure 2.1). In addition to these twelve genes, Ppp2r2a was included as a
candidate gene in further bioinformatic analyses due to its use as the sole reference gene for
previously published qPCR experiments from our laboratory. This resulted in a total of thirteen
genes used in the following bioinformatic analyses of candidate reference genes.
Reference genes (n=13) were evaluated for potential use in experiments comparing
nucleus accumbens in B6 and D2 male mice exposed to saline or 1.8 g/kg ethanol, and
amygdala from ethanol-naïve animals. As a preliminary screen, available nucleus accumbens
microarray data from previously published experiments (Kerns et al., 2005) were examined for
evidence of differential expression of candidate genes (n=13) between strains and ethanol dose
group. The results of this analysis are summarized in Table 2.3 and Table 2.4. One Actb
probeset located in the last two exons of the transcript indicated differential regulation of Actb by
ethanol between B6 and D2 mice in nucleus accumbens (|Sscore DBA/2J – SscoreC57BL/6J| > 2).
Available RMA values from microarrays in ethanol-naïve B6 and D2 mice indicate no difference
in basal expression of any of the thirteen genes in amygdala(Mozhui et al., 2010).
Candidate genes (n=13) and their associated transcripts (n=27) were assayed for
sequence similarity with unintended targets using the BLASTn algorithm. Of the original 13
candidate genes, five were eliminated due to overlap of their gene sequences with non-specific
transcripts or chromosomal areas, while an additional three were eliminated because one or
more of their transcript variants overlapped non-specific targets. This resulted in a list of five
candidate genes remaining: B2m, Canx, Ndufv1, Sdha, and Sort1. None of these had
pseudogenes. The workflow used and its results are shown in Figure 2.2.
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Primer design
The laboratory had previously designed primers for four out of five of the final candidate
genes – B2m, Canx, Ndufv1, and Sort1. In order to avoid binding of primers to parent gene loci
on potential genomic DNA contamination of samples, primer pairs were discarded if neither
primer overlapped an exon junction or one of the primers was located in the 3'-untranslated
region of a target transcript. Existing primers for B2m were the only primers that did not require
redesign based on these criteria. New primers for Canx, Ndufv1, Sort1, and Sdha were
designed using NCBI PrimerBLAST, and subsequently evaluated using UCSC in-silico PCR,
UCSC BLAT and/or NCBI BLAST, and IDT-UNA Fold. The alignment of all primers to their
target mRNAs are shown in Figure 2.3 and Figure 2.4; primer sequences are listed in Table 2.5.
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Figure 2.1 Overlap of Candidate Reference Gene Sets
Sets of genes from our laboratory (n=8), GeNorm kits (n=10), and an analysis of nucleus
accumbens (NAc) microarray data from our laboratory filtered for genes with high expression
levels (RMA values greater than 6.64) and no differential expression with acute ethanol
exposure (within-strain saline vs. 1.8g/kg ethanol |Sscores|<2) (n=4985).
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Gene
Symbol

Actb

Atp5b

B2m

Canx

Eif4a2

Ndufv1

Ppp2r2
a

Rpl13a

Saline RMA
ProbeSetID / RecordID

ProbeTarget

Ethanol RMA

Ethanol vs Saline
Sscore

C57BL/6
J

DBA/2
J

C57BL/6
J

DBA/2
J

C57BL/6J

DBA/2J

1419734_at

mid 3' UTR

10.277

10.299

10.255

10.153

-0.053

-0.714

1436722_a_at

exon 3, 4, 5 and proximal 3' UTR

14.491

14.306

14.556

14.302

0.814

-0.729

AFFX-bActinMur/M12481_3_at
AFFX-bActinMur/M12481_M_at
AFFX-bActinMur/M12481_5_at

last two exons (Affymetrix control, 3'-most probe set used to calculate 3':5'
ratio)

14.526

14.422

14.589

14.346

1.120

-1.160

exon 3 (Affymetrix control, middle probe set used to compute 3':5' ratio)

13.911

13.659

13.956

13.665

0.955

-0.661

exons 2 and 3 (Affymetrix control, 5'-most probe set used to calculate 3':5'
ratio)

14.036

13.780

14.081

13.805

1.018

-0.377

1416829_at

exons 8 and 9

14.144

14.109

14.109

14.114

0.140

-0.372

1427511_at

first intron

5.773

5.779

5.817

5.737

0.461

0.150

1452428_a_at

two exons

11.047

10.896

11.057

10.919

0.046

0.404

1449289_a_at

last two exons and 3' UTR

11.052

10.898

11.035

10.979

-0.168

1.056

1445045_at

NA

4.992

5.032

5.006

5.049

-0.089

-0.274

1428935_at

NA

8.775

8.737

8.784

8.672

-0.228

-0.684

1415692_s_at

mid 3' UTR

12.380

12.382

12.300

12.430

-0.348

0.265

1422845_at

last exon and proximal 3' UTR

10.972

10.874

10.809

10.995

-1.073

0.719

1450934_at

last exon and 3' UTR

13.856

13.880

13.821

13.883

0.293

-0.465

1456015_x_at

last exon and 3' UTR

11.987

12.076

12.011

12.064

0.464

-0.181

1415966_a_at

last exon

12.274

12.370

12.296

12.397

0.307

0.047

1415967_at

exons 7, 8, and 9 (of 10)

12.181

12.270

12.186

12.256

0.365

-0.187

1429715_at

NA

8.088

8.078

8.092

8.078

-0.273

-0.024

1437730_at

NA

12.097

11.940

12.065

11.900

0.079

-0.647

1453260_a_at

last exon and last intron

10.998

10.773

10.944

10.825

-0.026

0.495

1433928_a_at

NA

10.789

10.942

10.809

10.977

0.108

0.280

1455001_x_at

NA

11.659

11.730

11.736

11.759

0.682

-0.293

1455485_x_at

last three exons

13.888

13.842

13.947

13.848

0.794

-0.196

1435873_a_at

last two exons

13.841

13.832

13.915

13.840

0.892

-0.055

1417608_a_at

exons 3 and 4

13.302

13.236

13.324

13.238

0.905

0.300

Table 2.3 Nucleus Accumbens Microarray Data for Candidate Reference Genes
The Actb probe highlighted in red shows differential regulation by ethanol in B6 and D2 mice.
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Gene
Symbol

Sdha

Sort1

Ubc

ProbeSetID / RecordID

ProbeTarget

1426689_s_at

Ethanol RMA

Ethanol vs Saline Sscore

C57BL/6J

DBA/2J

C57BL/6J

DBA/2J

C57BL/6J

DBA/2J

mid-distal 3' UTR

12.012

12.066

12.015

12.033

0.172

-0.301

1426688_at

last two exons and proximal 3' UTR

12.496

12.481

12.497

12.503

0.277

-0.062

1445317_at

intron (not expressed)

7.600

7.481

7.655

7.400

0.278

-0.045

1433293_at

intron 1 (expressed)

8.686

8.671

8.807

8.656

0.934

0.318

1423363_at

proximal 3' UTR

9.480

9.190

9.339

9.452

-0.800

1.069

1450955_s_at

proximal 3' UTR

9.450

9.198

9.307

9.449

-0.579

0.992

1423362_at

distal 3' UTR

11.856

11.817

11.794

11.811

-0.465

-0.252

1432827_x_at

only coding exon

13.946

14.030

13.949

14.069

0.330

-0.124

1420494_x_at

only coding exon and 3' UTR

13.433

13.457

13.485

13.513

0.676

0.134

1425966_x_at

only coding exon and 3' UTR

12.196

12.205

12.206

12.233

0.113

0.109

1437666_x_at

only coding exon and 3' UTR

13.486

13.507

13.503

13.531

0.763

-0.128

1425965_at

NA

7.721

7.600

7.649

7.577

-0.186

-0.541

1438137_at

NA

6.971

7.050

7.039

7.065

0.914

-0.444

1458507_at

NA

7.332

7.509

7.443

7.479

0.113

-0.043

Ublcp1

Ywhaz

Saline RMA

Data Not Available
1416103_at

far 3' UTR

10.592

10.596

10.604

10.566

-0.110

0.125

1436971_x_at

distal 3' UTR

13.694

13.703

13.681

13.702

0.352

-0.336

1448218_s_at

mid distal 3' UTR

13.189

13.191

13.096

13.157

-0.179

-0.557

1439005_x_at

multiple probe targets (antisense to human Ywhaz sequence)

10.293

10.092

10.262

10.040

0.076

-0.126

1436981_a_at

antisense probe set in mid 3' UTR of Ywhaz (LTR element homology)

10.981

10.905

11.059

10.856

0.499

-0.008

1416102_at

mid-proximal 3' UTR

12.626

12.479

12.520

12.557

-0.341

0.012

1448219_a_at

mid 3' UTR

13.411

13.237

13.328

13.297

-0.235

-0.073

1443893_at

intron 2

5.354

5.325

5.432

5.399

-0.161

-0.068

Table 2.4 Nucleus Accumbens Microarray Data for Candidate Reference Genes (continued)
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Figure 2.2 Workflow for Candidate Gene Selection
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In vivo validation
RNA Sample Quality
Canx, Sort1, and Ndufv1 primers were analyzed first due to their immediate availability.
Ppp2r2a and Ublcp1 were also evaluated because of their broader applicability to ongoing
experiments in the laboratory. RNA sample quality for B6 and D2 amygdala and nucleus
accumbens was assessed prior to any qPCR experiments. Figure 2.5 shows the virtual gel
electrophoresis images and resulting RNA quality indicator (RQI) numbers from Experion runs
of the four samples used to produce temperature gradients and standard curves.
Primer evaluation
Annealing temperatures of primer pairs were evaluated using a 3-step qPCR protocol
with a plate temperature gradient spanning 10C and centered around the predicted melt
temperature of the primers as the annealing step. In order to reduce the number of agarose gels
run, qPCR products from sample reactions at the annealing temperature with the lowest Cq and
no-template control reactions at the lowest annealing temperature were evaluated. Primer pairs
Ublcp1 F/R2, and Ublcp1 F/R3, were discarded because more than one distinct band was
visible in the sample qPCR products (Figure 2.6). Standard curves were produced with
samples from one B6 and one D2 mouse using the annealing temperature with the lowest Cq
from remaining primer pairs for all genes except Canx and Sort1. Efficiency and R2 were
determined for each strain and brain region separately (Figure 2.7). Ndufv1 F/R2 primers were
excluded from further analyses in amygdala because both efficiencies were not between 80100%. The remaining primers (Canx F/R3, Sort1 F/R2, Ppp2r2a F/R, and Ublcp1 F/R4) were
used in subsequent experiments evaluating candidate reference genes in amygdala. Canx
F/R3, Sort1 F/R2, Ndufv1 F/R2, and Ublcp1 F/R4 were evaluated in NAc.
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Figure 2.3 New and Existing Primer Alignments

Primers are displayed as two arrows flanking the intended amplicon. The direction of the arrow indicates the direction of the primer.
Primers or amplicons highlighted in red indicate that they did not meet primer design criteria.
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Figure 2.4 New and Existing Primer Alignments (continued)

Primers are displayed as two arrows flanking the intended amplicon. The direction of the arrow indicates the direction of the primer.
Primers or amplicons highlighted in red indicated that they did not meet primer design criteria.
26

Existing Primers
Target Gene

Primer Pair Name

Forward Primer (5' to 3')

Reverse Primer (5' to 3')

B2m

B2m F/R1

GGAGAATGGGAAGCCGAACA

TCTCGATCCCAGTAGACGGT

Canx

Canx Fwd/Rev

TGGCAGTCAAGATGAGGAAG

GAAGGGGAGGGAGAGGAAAT

Ndufv1

Ndufv1 Fwd/Rev

GACCGTGCTAATGGACTTCG

GGCATCTCCCTTCACAAATC

Sort1

Sort1 Fwd/Rev

TTTATCAGTATGCCCCGAAT

CCATCAAACACAGGGACTCA

Ublcp1

Ublcp1 F2/R2

GCTAAAATGAAAGAGCTGGGCG

ACACCAAGAGGCTTCACGTC

New Primers
Target Gene

Primer Pair Name

Forward Primer (5' to 3')

Reverse Primer (5' to 3')

Canx F2/R2

CAGATGACTGGGATGAAGACGC

TTCCTTGGTTTCCAGATTCCCTG

Canx F3/R3

GCTTTGCCAGTGTTCCTTG

ATTTCATCCTCCTCTGCTTTAGG

Ndufv1

Ndufv1 F2/R2

ATGTGTTTGTGGTGCGTGGG

GGCATCCAAACACTCCCACATC

Sdha

Sdha F1/R1

AACTACAAGGGACAGGTGCTG

CCTCCCCACAGGCATACAG

Sort1

Sort1 F2/R2

CTCTATACCACCACAGGCGG

GAAGGCTGCACTCGTTCTTG

Ublcp1 F3/R3

AATGAAAGAGCTGGGCGTGA

CCCAAATGACACCAAGAGGC

Ublcp1 F4/R4

TCCTGGTGCTGGATGTTGAC

TCACGCCCAGCTCTTTCATT

Canx

Ublcp1

Table 2.5 New and Existing Reference Gene Primer Sequences
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Strain

Region

Sample
Name

D2
D2

NAc
Amygdala

9084N
9084A

20.48
50.96

RNA
Concentrati
on (ng/𝛍L)
152.02
59.91

B6
B6

NAc
Amygdala

9071N
9071A

148.34
65.49

74.15
32.74

RNA
Area

D9084A

D9084N

b)

Ladder

B9071A

B9071N

Ladder

a)

Ratio
[28S:18S]

RQI

1.33
1.57

9.4
8.9

1.17
1.14

8.8
9.3

RQI
Classification





Figure 2.5 RNA Quality Asessment of Samples Used for Standard Curves
a) Virtual gel image from NAc and amygdala of a B6 mouse
b) Virtual gel image from NAc and amygdala of a D2 mouse
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Canx and Sort1 are optimum reference genes to use in experiments evaluating gene expression
in ethanol dose-response experiments with B6 and D2 mice
Variability in expression of candidate reference genes was examined in amygdala from
B6 and D2 mice i.p. injected with 0 g/kg, 1.8 g/kg, or 4 g/kg ethanol (n = 7-8 per group). Mean
Cq values for each gene in amygdala are shown in Figure 2.8. No significant differences were
found between experimental groups for any of the genes in amygdala (two-way ANOVA, α =
0.05). GeNorm analysis of these results determined the optimum number of reference genes to
be 2-3 (V2/3 = 0.121, V3/4 = 0.189) and Canx and Sort1 to have the lowest amount of variability in
expression across experimental groups among the genes tested (M = 0.345, Figure 2.10). In
NAc from saline treated B6 and D2 mice, no significant differences were found between Mean
Cq for any of the genes studied (Figure 2.9); the most stable genes were Canx and Ublcp1
(Figure 2.11).
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Ubclp1 FR3; 131 bp
Ubclp1 FR2; 128 bp

Figure 2.6 Gel electrophoresis of Ublcp1 primer products

Red arrows show location of potential unintended product. N =
nucleus accumbens, A = amygdala. Note: The ladder and samples
shown in each image were run on the same gel. The whole gel
images have been cropped to remove wells with samples from
unrelated experiments
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Mean(Cq) & Cq vs. Log Starting Quantity
Region
Amy

35

Strain

NAc

Cq (B6) = 35.83 - 2.066*X
R² (B6): 0.86
Cq (D2) = 33.98 - 3.049*X
R² (D2): 0.92

B6

Cq (B6) = 29.23 - 4.253*X
R² (B6): 0.96
Cq (D2) = 30.86 - 3.713*X
R² (D2): 0.96

D2

Ndufv1 FR2

30

25

Efficiency (B6) = 71.8 %
Efficiency (D2) = 85.9%

Efficiency (B6) = 204.8 %
Efficiency (D2) = 112.8%

20

35

Cq (B6) = 26.42 - 3.607*X
R² (B6): 1.00
Cq (D2) = 26.86 - 3.718*X
R² (D2): 1.00

Efficiency (B6) = 88.4%
Efficiency (D2) = 99.4%

Efficiency (B6) = 89.3%
Efficiency (D2) = 85.8%

Target
Ppp2r2a

Cq (B6) = 28.1 - 3.634*X
R² (B6): 1.00
Cq (D2) = 27.77 - 3.637*X
R² (D2): 1.00

Cq 30

25

20

35

Cq (B6) = 32.44 - 3.235*X
R² (B6): 0.98
Cq (D2) = 31.1 - 3.844*X
R² (D2): 0.98

Cq (B6) = 28.81 - 3.924*X
R² (B6): 0.99
Cq (D2) = 30.91 - 3.901*X
R² (D2): 0.97
Ublcp1 FR4

30

25

Efficiency (B6) = 103.8%
Efficiency (D2) = 80.9%

Efficiency (B6) = 79.8%
Efficiency (D2) = 80.4%

20
-1.5

-1.0

-0.5

0.0

0.5

-1.5
Log Starting Quantity

-1.0

-0.5

0.0

0.5

Figure 2.7 Standard Curves for Candidate Reference Genes in NAc and Amygdala
Mean Cq ± SEM of three technical replicates of one sample per strain in each brain region.
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Target
Canx FR3

35

Strain

Ppp2r2a

B6
D2

30

Cq Mean

25

20
35

Sort1

Ublcp1 FR4

30

25

20

0 g/kg

1.8 g/kg

4 g/kg

0 g/kg

1.8 g/kg

4 g/kg

Dose

Figure 2.8 Mean Cq of Candidate Reference Genes Across Ethanol Doses and Strains In
Amygdala
Data are presented as mean ± SEM (n=6-8 per group). No significant differences were identified
with two-way ANOVA with Tukey's post-hoc tests (α = 0.05).
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Strain

35

B6
D2

30

Mean Cq

25

20

15

10

5

0

Canx FR3

Ndufv1 FR2

Sort1 FR2

Ublcp1 FR4

Target

Figure 2.9 Mean Cq of Candidate Reference Genes in Saline-treated B6 and D2 Nucleus
Accumbens
Data are presented as mean ± SEM (n=6-8 per group). No significant differences were identified
with two-way ANOVA with Tukey's post-hoc tests (α = 0.05)
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Average expression stability values of remaining control genes
0.6

Average expression stability M

0.55

0.5

0.45

0.4

0.35

0.3
Ppp

Ublcp1 FR4
<::::: Least stable genes
Most stable genes ::::>

Canx FR3
Sort1 FR2

Figure 2.10 GeNorm Ranking of Most Stable Reference Genes in Amygdala

Average expression stability values of candidate reference genes in amygdala (n=46) from B6 and D2
mice exposed to saline, 1.8g/kg ethanol, or 1.4 g/kg ethanol.

34

Figure 2.11 GeNorm Ranking of Most Stable Reference Genes in Nucleus Accumbens

Average expression stability values of candidate reference genes in nucleus accumbens (n=14) from
saline treated B6 and D2 mice
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Discussion
Prior to the evaluation and collection of the data presented in this chapter, the most
commonly used reference genes to evaluate target gene expression in NAc and other brain
regions of ethanol treated B6 and D2 male mice in our laboratory were Ppp2r2a and Ublcp1.
These genes and their primers were chosen based on prior experiments validating their use as
reference genes in ventral midbrain samples (Megan O’Brien, Miles laboratory; data not shown).
In light of the developing standards for reference genes proposed by (Vandesompele et al.,
2002), and in an effort to comply with MIQE guidelines (Bustin et al., 2009), new and existing
laboratory reference genes were assessed for use in future experiments in both amygdala and
NAc of B6 and D2 mice. Of the 13 genes initially considered, only B2m, Canx, Ndufv1, Sdha,
and Sort1 met all of the in-silico criteria used for selection of optimum candidates. Primers
were then designed and validated in B6 and D2 NAc and amygdala using melt curves and
standard curves to determine efficiency.
Based on GeNorm analyses, Canx and Sort1 were the two genes with the least
variability in amygdala of B6 and D2 mice from an acute ethanol dose-response experiment. At
a minimum, these two reference genes should be used in further qPCR experiments comparing
gene expression in amygdala from ethanol treated mice of these strains, followed in order by
Ublcp1 and Ppp2r2a. In NAc, candidate reference genes were only evaluated from salinetreated B6 and D2 mice. For experiments comparing basal gene expression in NAc of B6 and
D2 mice, Ublcp1 and Sort1 are the most stably expressed between strains, followed in order by
Canx and Ndufv1. Any comparison of B6 and D2 gene expression in NAc involving ethanol
exposure will require further evaluation of candidate reference gene stability under those
conditions.
It is important to note that Ppp2r2a was not present in the NAc microarray data from
saline and ethanol treated BXD strains filtered for genes that were not differentially regulated by
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ethanol (Kerns et al., 2005), particularly because of its use as the sole reference gene in
previous experiments in NAc of B6 and D2 mice in the laboratory. In fact, qPCR data from
ethanol-naïve B6 and D2 NAc suggests Ppp2r2a could be differentially expressed between the
strains (Figure 2.12). Furthermore, ~50% of each of four Ppp2r2a transcript variants has
greater than 90% sequence homology with a non-coding area of Chromosome 12, which makes
it very difficult to design primers that will bind specifically to cDNA from Ppp2r2a transcripts in
the presence of genomic DNA contamination. This would be less of an issue if total RNA
samples were DNAse-treated prior to reverse transcription, but unless that is a laboratory-wide
practice, target sequence similarity with genomic DNA needs to be considered when designing
primers. Regardless, because of the apparent differential expression of Ppp2r2a in B6 and D2
NAc under basal conditions, it is the recommendation of the author that Ppp2r2a no longer be
used as a reference gene in NAc for comparison of B6 and D2 gene expression. Similarly,
existing qPCR experiments comparing gene expression in B6 and D2 NAc that use Ppp2r2a as
a reference gene should be repeated with appropriately validated reference genes.
The difference in Ndufv1 primer efficiency between NAc and amygdala in both strains,
and the apparent differential expression between strains of Ppp2r2a in NAc, but not amygdala
highlights the need for validation of reference genes as well as their primers for any experiments
with new or unique conditions. Ndufv1 may be stably expressed in amygdala, but the low total
expression level of this gene makes that impossible to quantify in this region. Consequently,
reference gene primers validated in one experimental condition (in this case, brain region) may
not be appropriate for another. Conversely, the elimination of a candidate reference gene
because of variability between groups in one experiment does not preclude its use in a different
experiment where, for example, the same strains are used but a different brain region is being
examined. Perhaps the most important conclusion gathered from this work is that accurate
reporting of gene expression differences using relative quantification in qPCR requires
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evaluation of multiple reference genes across all groups for the specific experimental
paradigm being used.
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Figure 2.12 Ppp expression in NAc Normalized to Ublcp1
Data are presented as mean ± SEM (n=4 per strain). Pstudent's-t = 0.45
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Chapter 3 Ninein Characterization as a Functional Validation of the Use of Proper
Reference Genes
Introduction
Ninein was identified by our laboratory as a quantitative trait gene for ethanol induced
anxiolytic-like behavior in BXD mice. Ninein is a microtubule associated protein (MAP) typically
found at the minus end of microtubules in the centrosome, but has recently been identified in
the cytoplasm of all parts of embryonic cortical neurons in mice, playing a role in axon outgrowth
and branching (Srivatsa et al., 2015). There are 3 known NIN protein isoforms, and 6 known
Nin transcript variants in mice (Table 3.1). The D2 allele at a potentially deleterious SNP
(rs29159683) and another missense SNP (rs29192398) in these variants results in the creation
or alteration of an exon splice enhancer sequence that promotes the splicing of exon 18
(RefSeq NR_104397.2). The absence of exon 18 has been shown to result in the dissociation
of NIN peptides from the centrosome, and the presence of another exon (exon 29) results in
diffusion of NIN peptides throughout the cytoplasm. Perhaps more striking, NIN peptides
translated from these alternatively spliced variants are present almost exclusively in
differentiated neurons (Zhang et al., 2016). In NCBI’s current genome assembly, Nin transcript
variants containing exon 29 are labeled non-coding because the presence of this exon creates a
downstream frameshift resulting in a ‘premature’ stop codon, making these transcripts
suspected targets for nonsense-mediated mRNA decay. While the stop codon present in
transcript variants containing exon 29 is upstream of stop codons in other variants, the findings
of Zhang et al. suggest that the resulting protein is not dysfunctional, but rather localizes
differently than other isoforms. This may be problematic in mitotic cells where the primary
function of NIN is in the centrosome, but non-deleterious in post-mitotic cells such as neurons
where the stability of microtubules in or near dendritic spines plays an integral role in synaptic
plasticity.
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The provisional proteins NIN4 and NIN5 (see figure 7c in Putman et al. 2016), that were
differentially expressed in NAc of B6 in D2 mice, have molecular weights corresponding to the
predicted protein products of Nin transcript variants 5 and 6, containing exon 29. However, as
of the time of this writing, there is no evidence for the presence of either of these transcripts in
amygdala or nucleus accumbens of B6 or D2 mice in vivo.
In this chapter, basal expression of specific Nin transcript variants is examined in both
nucleus accumbens and amygdala of B6 and D2 mice using appropriately selected reference
genes from the previous chapter. The aim of these experiments is to validate the use of proper
reference genes while providing a structural/functional basis for the role of Ninein in Etanq1related behaviors.
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Primer Set

Exon(s)
Amplified*
5,6,7
16,17
("large exon")

Variant(s)
Targeted
All

Protein Product

Functional Significance

Varies

Varies

1-5

Varies

Localizes Nin to centrosome

NinTV1

1

NIN isoform 1

NinTV2,3

2,3

NIN isoform 2

NinTV4

4

NIN isoform 3

NinEx5,6,7
NinEx16,1
7

NinTV5,6

29

5,6

Unknown

NinTV6

Absence of
"large exon"

6

Unknown

Microtubule anchoring at
centrosome
Microtubule anchoring at
centrosome
Microtubule anchoring at
centrosome
Peptides localize away from
centrosome;
Peptides localizes away from
centrosome AND throughout
cytoplasm

Tissue
Presence
Varies
Somatic,
Nervous
Somatic,
Nervous
Somatic,
Nervous
Somatic,
Nervous
Neurons
Neurons

Table 3.1 Targeted Ninein transcript variants and protein isoforms
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Methods and Materials
Experimental Subjects
C57BL/6J (n=8) and DBA/2J (n=8) male mice were obtained at 8 weeks of age from
Jackson Laboratories (Bar Harbor, ME) and housed 4 per cage on ventilated racks with Teklad
Sani-Chip bedding and cotton nesting material. All animals had ad libitum access to Teklad LM485 7012 standard rodent chow and water under a 12-hour light-dark cycle. After two weeks,
animals were sacrificed via cervical dislocation followed by decapitation. Immediately following,
whole brains were removed and dissected as described in Kerns et. al, 2005. Tissue sections
were placed in individual tubes, flash frozen in liquid nitrogen, and stored in a -80C freezer until
further use. All experimental procedures were approved by Virginia Commonwealth University
Institutional Animal Care and Use Committees in accordance with NIH guidelines.

Nucleic acid extraction and evaluation
Total RNA was isolated from amygdala tissue as described previously (Kerns et al.,
2005) using homogenization in STAT-60 (Tel-test, Inc., Friendswood, TX, USA) followed by
RNA purification with a Qiagen RNeasy Mini Kit (Qiagen, Redwood City, CA, USA). RNA
concentration in was quantified based on UV-Vis absorbance at 260nm using a ThermoFisher
Nanodrop 2000 Spectrometer. Sample quality was determined using RNA quality indicator
(RQI) values acquired from a Bio-Rad ExperionTM Automated Electrophoresis System with
Experion RNA StdSens analysis kit. Samples with RQI values lower than 7.0 were not included
in qPCR experiments.

qPCR
cDNA was synthesized from 500 ng total RNA using Bio-Rad iScript cDNA Synthesis Kit.
RT-qPCR was performed using Bio-Rad Universal SYBR Green Supermix in conjunction with
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Bio-Rad CFX Connect Thermocycler. Bio-Rad CFX Manager Software was used for calculation
of Cq values and relative normalized expression. Cqs were determined using the single
threshold method, and relative normalized expression was determined using ΔΔCq method with
two reference genes: Ublcp1 and Canx. Target gene and transcript primers were designed and
validated using the same procedure described in 0. Specific primer sequences can be found in
Appendix 2.

PCR Product Isolation and Sequencing
Following qPCR, reaction mixture from one amygdala sample containing primers that
would amplify Nin transcript variant 6 was run with 4% agarose and 1X GelRed (Biotium,
Fremont, CA, USA) in 1X TBE at 90 volts. Bands were visualized using a Kodak Image Station
and Kodak 1D Image Analysis Software (Eastman Kodak, Rochester, NY). The resulting band
corresponding to the predicted molecular weight of an exon-18-lacking product was isolated
using a QIAquick Gel Extraction Kit (Qiagen, Redwood City, CA, USA). Purified qPCR product
and transcript variant 6 qPCR primers were sent to Eurofin Genomics DNA sequencing services
(Louisville, KY, USA) for sequencing. The resulting sequence overlap was analyzed using
NCBI Nucleotide BLAST.

Statistical Analyses
All statistical analyses were performed using JMP Pro 13 statistical software (SAS, Cary,
NC, USA). Strain-mean relative normalized expression for each gene was compared using
student’s t-tests, and groups were considered significantly different if p<0.05.
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Results
Functional validation of reference genes for measuring basal gene expression in B6 and
D2 mice
qPCR was used to compare two reference genes in nucleus accumbens (NAc) of
ethanol-naïve B6 and D2 male mice. Figure 3.1a shows the mean Cq values for Actb and
Ublcp1 in these samples. Although the strain-mean Cq difference does not reach statistical
significance (p=0.3081, student's t-test), the variability of Actb expression between both mouse
strains results in the appearance of otherwise non-existent strain differences in expression of a
target transcript, Ninein transcript variant 1 (NinTV1), when it is used as a reference gene.
Figure 3.1b shows the same NinTV1 qPCR data (Cq) normalized to Actb, both Actb and Ublcp1,
and Ublcp1 alone. The significant difference in expression between strains observed when Actb
is used as a reference gene alone (p=0.0016), and paired with Ublcp1 (p<0.0001), is no longer
evident when Ublcp1 is used as the sole reference gene (p=0.3002). In addition, when Actb is
paired with Ublcp1 the M-value reflecting pair-wise reference gene stability is higher than the
recommended value for heterogenous samples (MActb/Ublcp1 = 1.2063). Further, a two-way
ANOVA revealed a significant effect of reference gene(s) used (p=0.0003) and a significant
interaction of reference gene(s) used with strain effect (p=0.0069) on relative normalized
NinTV1 expression. The significance of this interaction is eliminated when examining target
genes that exhibit much larger differences in expression between strains, as is the case with
Stab2 (Figure 3.1c, preference gene(s)=0.6796, pstrain<0.0001, pinteraction=0.5539).

Detailed characterization of Ninein expression in B6 and D2 mice
Basal expression of all six Nin transcript variants, exons of interest, and total Nin
expression was also examined via qPCR in nucleus accumbens and amygdala. Basal
expression of these targets normalized to Ublcp1 in nucleus accumbens is shown in Figure
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3.2a. Nin transcript variant 4 is the only transcript with significant differences in expression
between strains in NAc (p=0.02638). Additionally, total Nin, transcript variants 2 and 3 together,
and transcript variants 5 and 6 together had near significant differences in expression in nucleus
accumbens (pTotalNinein=0.0649, pNinTV2,3=0.0890, pNinTV5,6=0.0886). In all cases, expression of
these transcripts was higher in D2 NAc than B6 NAc. Of particular importance is the
amplification of transcript variants 5 and 6, which have not been previously observed in this
brain region in vivo in adult mice.
After seeing amplification of Nin transcript variants 5 and 6 in NAc, new primers were
designed specifically to target transcript variant 6 in amygdala. The forward primer of this set
overlapped the junction between the exon immediately upstream and immediately downstream
of the "large exon" present in Nin transcripts 1-5. This exon is responsible for the localization of
Ninein at the centrosome, and its absence results in re-localization of Ninein away from the
centrosome in neurons in vitro (Yu et al., 2009; Zhang et al., 2016). As of this writing, we are
aware of no published record of this transcript found in vivo in amygdala in adult mice.
Expression of the large exon in Ninein and transcript variants 1, 4, 5, and 6 normalized to Canx
and Ublcp1 is shown in Figure 3.2b. Significant differences between strains were found for
NinTV1 (p=0.0028) and NinTV5,6 (p=0.0024). NinTV6 primers amplified a product in both
strains, and while there was a small difference between strains it did not reach statistical
significance (p=0.2827). The product of this reaction was isolated and sequenced; its sequence
overlap with Nin transcript variants is shown in Figure 3.3. NCBI's BLAST algorithm identified a
99% overlap, including one mismatch and zero gaps, with 100% of the sequenced PCR product
with the intended NinTV6 target. The next five closest matches are with NinTVs 1-5 in regions
that share exons with NinTV6 downstream of the junction covered by the forward primer.
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Figure 3.1 Actb1 and Ublcp1 as Reference Genes for B6 and D2 Nucleus Accumbens

Data are presented as strain-mean ± SEM. a) Strain-mean Cq of Actb and Ublcp1 in nucleus accumbens. No significant differences were
observed using student’s t-test (α=0.05). b) and c) Comparison of expression of NinTV1 and Stab2 normalized to Actb alone, Actb and
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Strain means ± SEM of relative normalized expression of Ninein exons and transcript variants.
Significant differences determined using student’s t-tests with α=0.05. *p<0.05, **p<0.01, ~p<0.1
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Figure 3.3 Sequenced PCR Product Overlap with Nin Transcript Variants

The PCR product isolated from PCR in B6 amygdala uniquely overlaps the sequence of NinTV6, which excludes the "large exon"
responsible for localization of NIN to the centrosome. Thick blue bars represent exons, while thin arrowed lines represent introns. It
should be noted that due to limitations in the ability to incorporate multiple features in the file type necessary to display these images,
that the single mismatch present at chr12:70055152 is not shown in this diagram.
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Discussion and Future Directions
Proper selection of reference genes for a particular qPCR experiment is vital for
obtaining accurate results. In the case of Ninein in B6 and D2 nucleus accumbens and
amygdala, quantifying differences in expression of specific exons or transcripts requires the
ability to detect very small differences in target quantities. When comparing Actb and Ublcp1 as
reference genes in nucleus accumbens it is clear that, despite the lack of statistical significance,
higher variability in expression of a reference gene such as Actb greatly alters the appearance
of strain differences in expression of Ninein transcript variant 1. This is true even when paired
with Ublcp1, which has less variability in mean Cq across strains. On the other hand, small
variability in reference gene expression across experimental conditions is less relevant when
observing targets with very large differences in expression. For example, in the case of Stab2,
the change in expression between B6 and D2 mice is apparent regardless of the reference
gene(s) used for normalization. Identifying small differences in gene expression will be crucial
in ethanol-related behavioral experiments where the differences in single gene expression are
often less than 30%, and the response of the network of genes that are co-regulated with a GOI
likely contributes more to a given behavioral phenotype than the GOI alone (Kerns et al., 2005;
van der Vaart et al., 2017; Wolen et al., 2012).
Interestingly, the Bio-Rad CFX Manager software used for calculating normalized
expression of targets relative to reference genes shows a higher coefficient of variance (CV) for
Ublcp1 compared to Actb, which suggests higher variability in Ublcp1 expression across
samples. This is notable because, when looking at the mean Cq data, the standard deviation of
mean Cq of Ublcp1 across all samples (0.536) is almost three-fold less than that of Actb
(1.461). It is also clear in the comparisons shown in Figure 3.1b that the inclusion of Actb as a
reference gene dramatically changes the conclusions that can be drawn from looking at
normalized gene expression data. This discrepancy highlights the need for careful examination
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of data and calculations produced by qPCR analysis software, rather than a blind reliance on its
output. Perhaps more importantly, this further illustrates the need for validation of more than
two potential reference genes when normalized expression is to be used as the primary metric
for comparing target gene expression across experimental conditions. Because the analysis of
Ninein in nucleus accumbens was done prior to the evaluation of multiple other reference
genes, Actb and Ublcp1 were run based on their previous use for similar experiments in the
laboratory. qPCR data regarding detailed nucleus accumbens Nin characterization in this
chapter are presented normalized only to Ublcp1. Future experiments aiming to reproduce or
expand upon these results in nucleus accumbens from control and ethanol treated animals
should be preceded by a more thorough evaluation of potential reference genes in all
experimental groups, as described in the previous chapter.
That said, basal D2 expression of NinTV4 in nucleus accumbens was significantly
greater than B6 expression. This was accompanied by similar trends towards higher D2
expression of total Nin, Nin variants 2 and 3 together, and Nin variants 5 and 6 together. In
amygdala, B6 expression of NinTV1 was significantly greater than that of D2, while D2
expression of Nin variants 5 and 6 together was higher than B6. There was also a small trend
towards greater expression of NinTV4 in D2 amygdala versus B6. First, it is important to verify
that the expression of these transcript variants does correspond to expression of the associated
proteins which can be verified by western blot. While the general function of known Ninein
isoforms 1 through 3 is minus-end microtubule anchoring to the centrosome (BoucksonCastaing et al., 1996; Mogensen et al., 2000), there is little known about the differences in
function or localization, if any, between these 3 isoforms. Assuming gene expression and
protein expression are directly related, the expression differences of Nin variants 2 and 3
(Ninein isoform 2) and variant 4 (Ninein isoform 3) contrasted with the differences in NinTV1
expression (Ninein isoform 1) in both NAc and amygdala provides a basis for the hypothesis
that there is some functional difference between the isoforms. Because Nin transcript variants
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1-4 were initially observed in fibroblasts (Bouckson-Castaing et al., 1996; Mogensen et al.,
2000), then characterized in epithelial cells (Moss et al., 2007), and cortical neural progenitor
cells and post-mitotic neurons (Zhang et al., 2016) during embryonic development, it is difficult
to elucidate implications regarding strain differences in these transcripts in adults without further
cell-specific experiments.
Prior to the experiments in this chapter, the only evidence of Nin transcript variants 5
(TV5) and 6 (TV6) was confined to embryonic cortical neurons in vitro (Zhang et al., 2016).
While the difference in expression of NinTV5,6 relative to NinTV6 suggests, at a minimum, the
presence of TV5, the data presented do not directly confirm this. Sequencing of the amplified
product of NinTV6, however, does directly confirm the presence of this transcript despite it being
labeled as a target for nonsense mediated decay (NMD) in the most recent version of the
mouse genome (GRCm38.p6, 2017). Although it is possible that the NinTV5,6 and NinTV6
products we see in these qPCR experiments are just present prior to being removed via NMD,
Putman et al. (2016) suggests otherwise. A western blot in nucleus accumbens using an
antibody that binds to Ninein isoforms 1-3, and what would be the predicted protein products of
NinTV 5 and 6 shows more than the three bands that would be expected if known Ninein
isoforms were the only proteins translated from existing transcripts. In this blot, there are two
visible bands between 117KDa and 170KDa that could correspond to the predicted molecular
weight of the protein product of NinTV6 (~147KDa) labeled NIN4 and NIN5. Further, D2 mice
have significantly higher levels of both of these provisional proteins, which parallels the higher
levels of NinTV5,6 observed in NAc. Evaluation of strain differences in NinTV6 expression in
NAc via qPCR and sequencing of the proteins at bands NIN4 and NIN5 are needed to further
validate this theory.
Because we know that peptides resembling Nin variants 5 and 6 are unique to
differentiated neurons (Zhang et al., 2016), higher expression of these variants in D2 mice could
imply either a greater quantity of neurons or a greater potential for plasticity in existing neurons.
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In amygdala, the significant difference in expression of NinTV5,6 versus the lack of significance
in expression of NinTV6 alone suggests that a majority of the difference observed results from
differences in expression of NinTV5. Since NinTV6 is a splice variant of NinTV5, it is impossible
to quantify NinTV5 directly using qPCR with a single fluorophore; multiplex qPCR would be
better suited for this task. Splicing of the "large exon" of NinTV5 to form NinTV6 results in
dissociation of Ninein from the centrosome and diffuse localization throughout the cytoplasm.
This also highlights the importance of the ratio of NinTV5 to NinTV6. If there is a higher quantity
of NinTV5 relative to NinTV6, and this ratio is larger in D2 mice than in B6 mice, this suggests a
greater potential for either quick axonal outgrowth and branching in nascent adult neurons, or a
greater potential for synaptic plasticity in D2 mice due to increased stabilization of microtubules
in newly formed dendritic spines or axon terminals. In these scenarios, NinTV5 would act as a
readily available precursor for NinTV6 that is spliced and translated upon cellular responses to a
stimulus that result in the formation of new synapses or neurons guided by microtubule
outgrowth and stabilization. It would be interesting to look at expression of known Ninein
transcription and splice factors such as Sip1 and Qki5, respectively (Hayakawa-Yano & Yano,
2019; Srivatsa et al., 2015) in order to shed more light on whether NinTV6 in adult NAc and
amygdala plays a role in adult neurogenesis or in synaptic plasticity in postmitotic neurons.
Validating Ninein as a quantitative trait gene for ethanol-induced anxiolytic-like behavior
will require characterization of Nin transcript variant expression in nucleus accumbens before
and at different time points after restraint stress, ethanol exposure, and both. It will also require
validation of the NIN4 and NIN5 sequence. In addition, incorporating female mice into these
experiments is pertinent given the sex and sex*strain effects on anxiety-like behavior in certain
BXD strains with and without an acute dose of ethanol (Putman, 2008). One study in rats
identified different light-dark transition-related behavioral QTL not only between sexes, but also
across estrous cycle stages (Izídio et al., 2011), which raises the possibility that Etanq1 may not
be reproducible in female mice of the same BXD strains. This suggests that female anxiolytic53

like response to ethanol may be mediated by a different and/or more complicated mechanism
than occurs in males.
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Appendix 1 qPCR Temperature Gradient Protocols
Ndufv1F2/R2, Ublcp1 F2/R2, Ublcp1F3/R3, Ublcp1 F4/R4
Melt Curve

Denaturation
Annealing
Extension

Canx F2/R2, Canx F3/R3, Sort1 F2/R2

Denaturation

Melt Curve

Annealing
Extension
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Appendix 2 Ninein Primer Sequences
Primer Set
NinEx5,6,7

Forward (5' -> 3')
TGGTTTCCATCTGCGAACAG

Reverse (5' -> 3')
CATCGAAAGACTGCATAGAGAGA

NinEX16,17 AGTTAGGCAAAAAGACGCCC
NinTV1
CTGCCCGAGTTTCAAGAGTC

AGCTTTTCAGATTCATATCTCAGGA
ATTCAGGTCATCTGGGTTCC

NinTV2,3
NinTV4

ACAGGTGAGACTGGACGAGAA
GAAGAAACAGATGCAGCCCCT

AGCAAAGCCTGTGGTGTGTT
TTCAGAGGTGCCCAATCCTTCT

NinTV6

TCCAGGAGGGAAGATATGAATCTG

GGGAGTTCTTTTGGCTGAGTTC
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